Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
AfterEther

AfterEther

ICO Active
15,937 Views
Visit Website
Last screenshot taken on
25 Feb 2020 .
Add to Watchlist
AfterEther is a project to create another network of Ethereum. It is going to be exactly the same technology, but it will be cheaper, and it will not have the transaction bottleneck problem like in Ethereum's Main Net. Our Ether-like currency is called AfterEther(AET) , it is not a fork, it starts from block 0, so, there is a lot of room to mine it. Your DApps will be 100% compatible with Ethereum's DApps and you will be able to run them with a much lower gas price, saving money on every contract execution. Forget about paying high transaction fees to buy a token, with AfterEther this injustice is over.
Cryptocurrency
2.3
TOTAL SCORE
3.8
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 10 Mar 2018 - TBA
Country: Belize
Token info
Ticker: AET
Platform: Ethereum
Financial
ICO Price: 1 AET = 0.80 USD
Accepting: ETH
Hard cap: 1 000 000 AET
Social media
Facebook
Twitter
Screenshots taken on 5 Feb 2018
HORIZONTAL
SQUARE
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
flyxcoin
FlyX Coin powers FlyX Pay, a number-to-number crypto transaction platform enabling seamless, borderless, and instant payments.
Active
Bitopex
"Bitopex – The Retail-Focused Crypto Options Exchange Bitopex is an innovative cryptocurrency options exchange built from the ground up to make professional trading strategies accessible to everyone. Fully bootstrapped and independent since 2023, Bitopex is not backed by venture capital or external investors – giving us the freedom to stay focused on what truly matters: delivering value to our users. At the core of Bitopex is our mission to simplify and democratize options trading. While traditional options markets are complex and often limited to institutional players, Bitopex has created intuitive tools that allow retail traders to benefit from the same strategies in just a few clicks. Our standout feature, Option Cards, enables traders to enter predefined strategies instantly without navigating complicated order books. Combined with our proven Copy Trading system, which allows users to follow and automatically replicate the trades of experienced option traders, Bitopex empowers beginners and advanced users alike to participate in the fast-growing world of crypto derivatives. For those eager to learn, Bitopex offers comprehensive education, including a structured video course designed to take users from beginner to advanced in crypto options trading. Alongside our educational resources, our community-driven approach ensures that traders are supported, informed, and engaged at every step. Key Highlights: Retail-Focused: Designed for everyday traders, not just professionals. Option Cards: One-click trading strategies for simplicity and speed. Copy Trading: Proven strategies replicated in real time. Independent & Bootstrapped: Built without VC or external influence. Education First: Free learning resources to help traders master options. Consistent Performance: Strategies with strong historical results Bitopex combines cutting-edge trading features with transparency, education, and a strong community focus. Our goal is not only to provide a platform for profitable trading but also to become the leading destination for retail traders who want to explore and master the world of crypto options." Bitopex is a retail-focused crypto options exchange that makes professional trading strategies simple and accessible. With unique features like Option Cards (one-click strategies), Copy Trading, and a strong focus on education, Bitopex empowers everyday traders to master options and achieve consistent performance — all without VC backing, fully bootstrapped since 2023.
Upcoming
Verity
Verity makes it easy for people to get paid for reporting on real-time events and information around them, while developers can get any data they want in a cheap, fast and secure data feed. It uses sub-ms network to process data with wisdom of the crowd approach and uses blockchain‑as‑a‑court‑system on Ethereum network to guarantee security and fairness.
Upcoming
MetaShooter
Metashooter is the first decentralized blockchain-based hunting metaverse that joins millions of hunting enthusiasts in a community where they can: Experience real hunting: Play in tournaments, multiplayer, and with stunning visuals with VR compatibility; Hunt & Earn: Receive token rewards by hunting trophies, wining tournaments, and more; Customize & Upgrade: Buy, upgrade hunting equipment and customize your hunter; Develop: Buy hunting lands, build towers, breed NFT dogs, and earn passive income; Explore the open World: Experience various environments, stunning visuals and realistic dynamics.
Upcoming
Mind AI
Mind AI is an artificial intelligence engine that is capable of human-like abstract reasoning without the need for big data or supercomputers. With its ability to contextualize information and reason, Mind AI is able to generalize knowledge, a feat that no other AI today is capable of. By being able to learn on its own, Mind AI will be able to formulate its own hypotheses and models of how things work, augmenting human intelligence.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.